Phototoxicity of some novel porphyrin hybrids against the human leukemic cell line TF-1

Journal of Photochemistry and Photobiology B: Biology

Volumn 40, Issue 3, 1997, Pages 263-272

  Viola, A ^d   Mannoni, P ^b   Chanon, M ^a   Julliard, M ^a   Mehta, G ^c   Maiya, B G ^c   Muthusamy, S ^c   Sambaiah, T ^c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c UNIVERSITY OF HYDERABAD   (India)

^d NONE

Author keywords

23H porphin; 5,10,15,20 Tetra p tolyl 21H; 9(10H) acridone; 9 Aminoacridine; Phototoxicity; Porphyrin acridone diad; Porphyrin chlorambucil diad; Porphyrin cholic acid chlorambucil triad; TF 1 cell line; Toxicity

Indexed keywords

ACRIDINE; ACRIDONE DERIVATIVE; CHLORAMBUCIL; CHOLIC ACID; INTERCALATING AGENT; PORPHYRIN DERIVATIVE; PROPIDIUM IODIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DARKNESS; DNA CROSS LINKING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; LIGHT; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL;

ACRIDINES; CROSS-LINKING REAGENTS; DARKNESS; HUMANS; INTERCALATING AGENTS; MOLECULAR STRUCTURE; PHOTOSENSITIZING AGENTS; PORPHYRINS; TUMOR CELLS, CULTURED;

EID: 0030669378     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(97)00067-5     Document Type: Article

References (51)

1. T.J. Dougherty, Photodynamic therapy, Photochem. Photobiol., 58 (1993) 895-900.
2. L.C. Penning, T.M.A.R. Dubbleman, Fundamentals of photodynamic therapy: Cellular and biochemical aspects, Anti-Cancer Drugs, 5 (1994) 139-146.
3. B.W. Henderson, T.J. Dougherty, How does photodynamic therapy work? Photochem. Photobiol., 55 (1992) 145-157.
4. A.J. Mac Robert, D. Phillips, Photodynamic therapy, Chemistry and Industry (1992) 17-20.
5. J.S. Nelson, L.H. Liaw, M.W. Berns, Tumor destruction in photodynamic therapy, Photochem. Photobiol., 46 (1987) 829-835.
6. T.J. Dougherty, Photosensitizers: therapy and detection of malignant tumors, Photochem. Photobiol., 45 (1987) 879-889.
7. J. Moan, K. Berg, Photochemotherapy of cancer: experimental research, Photochem. Photobiol., 55 (1992) 931-948.
8. C.J. Gomer, Photodynamic therapy in the treatment of malignancies, Semin. Hematol., 26 (1989) 65-72.
9. C.J. Gomer, Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem. Photobiol., 54 (1991) 1093-1107.
10. M. Jin, B. Yang, W. Zhang, Y. Wang, Photodynamic therapy for upper gastrointestinal tumours over the past 10 years, Semin. Surg. Oncol., 10 (1994) 111-113.
11. T.C. Origitano, M.J. Caron, O.H. Reichman, Photodynamic therapy for intracranial neoplasms. Literature review and institutional experience, Mol. Chem. Neuropathol., 21 (1994) 337-352.
12. H.I. Pass, J.S. Donington, Use of photodynamic therapy for the management of pleural malignancies, Semin. Surg. Oncol., 11 (1995) 360-367.
13. M.A. Biel, Photodynamic therapy of head and neck cancers, Semin. Surg. Oncol., 11 (1995) 355-359.
14. D. Kessel, Tumor localization and photosensitization by derivatives of hematoporphyrin: a review, IEEE J. Quant. Elect., QE-23 (1987) 1718-1720.
15. A.R. Morgan, Strategies for the development of photodynamic sensitizers, Curr. Med. Chem., 2 (1995) 604-615.
16. R. Bonnett, Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy, Chem. Soc. Rev., (1995) 19-31.
17. D. Dolphin, Photomedicine and photodynamic therapy, Can. J. Chem., 72 (1994) 1005-1013.
18. M. Kreimer-Birnbaum, Modified porphyrins, chlorins, phthalocyanines and purpurins: second-generation photosensitizers for photodynamic therapy, Semin. Hematol., 26 (1989) 157-173.
19. I. Rosenthal, Phthalocyanines as photodynamic sensitizers, Photochem. Photobiol., 53 (1991) 859-870.
20. K. Rezka, J.A. Hartley, J.W. Lown, Photosensitization by selected anticancer agents, Biophys. Chem., 35 (1990) 313-323.
21. A.J. Mac Roberts, S.G. Bown, D. Phillips, in G. Bock, S. Harnett (Eds.), What are the ideal properties for a sensitizer in photosensitizing compounds: their chemistry, biology and clinical use (Ciba Foundation symposium 146), Wiley, Chichester, 1989, pp. 4-12.
22. D. Phillips, The photochemistry of sensitizers in photodynamic therapy, Pure Appl. Chem., 67 (1995) 117-126.
23. F. Sieber, Phototherapy, photochemotherapy and bone marrow transplantation, J. Hematotherapy, 2 (1993) 43-62.
24. D. Magda, M. Wright, R.A. Miller, J.L. Sessler, P.I. Sansom, Sequence specific photocleavage of DNA by an expended porphyrin with irradiation above 700 nm, J. Am. Chem. Soc., 117 (1995) 3629-3630.
25. P. Bigey, G. Pratviel, B. Meunier, DNA photocleavage by a metalloporphyrin-spermine-oligonucleotide molecule, J. Chem. Soc. Chem. Commun., (1995) 181-182.
26. L. Mastruzzo, A. Woisard, D.D.F. Ma, E. Rizzarelli, A. Favre, T. Le Doan, Targeted photochemical modification of HIV derived oligonucleotides by antisense oligonucleotides linked to porphyrins, Photochem. Photobiol., 60 (1994) 316-322.
27. L.R. Milgrom, F. O'Neill, Towards synthetic-porphyrin/monoclonal antibody conjugates, Tetrahedron, 51 (1995) 2137-2144.
28. A. Harada, K. Shiotsuki, H. Fukushima, H. Yamaguchi, M. Kamachi, Supramolecular assembly of porphyrins and monoclonal antibodies, Inorg. Chem., 34 (1995) 1070-1076.
29. M. Momenteau, D. Oulmi, P. Maillard, A. Croisy, In vivo photobiological activity of a new series of photosensitizers: the glycoconjugated porphyrins, Photodynamic therapy of cancer II, SPIE, 2325 (1994) 13-23.
30. B.A. Klyashchitsky, I.S. Nechaev, G.V. Ponomaryov, Approaches to targeted photodynamic tumor-therapy, J. Controlled Release, 29 (1994) 1-16.
31. L. Ding, G. Etemad-Moghadam, B. Meunier, Oxidative cleavage of DNA mediated by hybrid metalloporphyrin-ellipticine molecules and functionalized metalloporphyrin precursors, Biochemistry, 29 (1990) 7868-7775.
32. E. Reil, M. Soll, K. Masson, W. Oettmeier, Acridones and quinolones as inhibitors of ubiquinone functions in the mitochondrial respiratory chain, Biochem. Soc. Trans., 22 (1994) 213-216.
33. W. Oettmeier, K. Masson, M. Soll, The acridones, new inhibitors of mitochondrial NADH: ubiquinone oxidoreductase (complex I). Biochim. Biophys. Acta, 1099 (1992) 262-266.
34. G. Mehta, T. Sambaiah, B.G. Maiya, M. Sirish, D. Chatterjea, Synthesis and nuclease activity of porphyrin-acridone hybrid molecules, J. Chem. Soc. Perkin Trans, 1 (1993) 2667-2670.
35. T.L. Su, T.C. Chou, J.Y. Huang, G. Ciszewska, W.Y. Ren, G.M. Otter, F.M. Sirotnak, K.A. Watanabe, 9-substitued acridine derivatives with long half-life and potent anti-tumor activity: Synthesis and structure-activity relationships, J. Med. Chem., 18 (1995) 3226-3235.
36. L.R. Ferguson, W.A. Denny, Frameshift mutagenesis by acridines and other reversibly-binding ligands, Mutagenesis, 4 (1990) 529-540.
37. G. Mehta, T. Sambaiah, B.G. Maiya, M. Sirish, A. Dattagupta, Porphyrin-phenothiazine hybrid molecules: Marked dependence of light-induced nuclease activity on the linker chain, J. Chem. Soc. Perkin Trans., 1 (1995) 295-297.
38. R.R. Gupta, Phenothiazines and 1,4-Benzothiazines: Chemical and Biochemical Aspects, Elsevier, Amsterdam, 1988.
39. G. Mehta, T. Sambaiah, B.C. Maiya, M. Sirish, A. Dattagupta, Porphyrin-chlorambucil conjugates: synthesis and light-induced nuclease activity, Tetrahedron Lett., 35 (1994) 4201-4204.
40. F. Morabito, C. Stelitano, I. Callea, M. Filangeri, B. Oliva, G. Sculli, V. Callea, F. Nobile, M. Brugiatelli, In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with hematological and immunophenotypic features, Haematologica, 81 (1996) 224-231.
41. L. Elias, D. Stock-Novack, D.R. Head, M.R. Grever, J.K. Weick, R.A. Chapman, J.E. Godwin, E.N. Metz, F.R. Appelbaum, A phase I trial of combination of fludarabine monophosphate in chronic lymphocytic leukemia: a southwest oncology group study, Leukemia, 7 (1993) 361-365.
42. S.M. Kelsey, A.C. Newland, G.V. Hudson, A.M. Jelliffe, A british national lymphoma investigation randomised trial of single agent chlorambucil plus radiotherapy alone in low grade localised non-Hodgkins lymphoma, Med. Oncol., 11 (1994) 19-25.
43. A. Begleiter, K. Lee, L.G. Israels, M.R. Mowat, J.B. Johnston, Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy, Leukemia, 8 Suppl. 1 (1994) S103-106.
44. M. Weiss, T. Spiess, E. Berman, S. Kempin, Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia, Leukemia, 8 (1994) 1290-1293.
45. G. Mehta, S. Muthusamy, B.G. Maiya, M. Sirish, Porphyrin-cholic acid-chlorambucil triads: Synthesis and light-induced nuclease activity, J. Chem. Soc. Perkin Trans, 1 (1996) 2421-2423.
46. J. Piette, New trends in photobiology (invited review), Biological consequences associated with DNA oxidation mediated by singlet oxygen. J. Photochem. Photobiol., 11 (1991) 241-260.
47. A.M. Khalil, R.A. Khatib, A.L. Shamseddine, N.H. Sharara, M.A. Seaud, Prolonged intake of chlorambucil for ovarian cancer, Eur. J. Obstet. Gynecol. Reprod. Biol., 60 (1995) 85-86.
48. T. Kitamura, T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y. Piao, K. Miazono, A. Urabe, F. Takrarn, Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 or erythropoietin, J. Cell Physiol., 140 (1989) 323-334.
49. M. Fiedorowicz, J.R. Galindo, M. Julliard, P. Mannoni, M. Chanon, Efficient photodynamic action of Victoria Blue BO against the human leukemic cell lines K-562 and TF-1, Photochem. Photobiol., 58 (1993) 356-361.
50. O.M. Smith, K. Qiu, P.L. Witt, E.C. Borden, F. Sieber, Merocyanine 540 and two phase partitioning detect interferon-bSER-induced plasma membrane alteration in DAUDI lymphoma cells, Cancer Res. Therapy and Control, 3 (1993) 87-93.
51. J.P. Daziano, S. Steenken, C. Chabannon, P. Mannoni, M. Chanon, M. Julliard, Photophysical and redox properties of a series of phthalocyanines: relation with their photodynamic activities on TF-1 and DAUDI leukemic cells, Photochem. Photobiol., 64 (1996) 712-719.